Literature DB >> 6415162

NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.

H H Peter, W Friedrich, R Dopfer, W Müller, C Kortmann, W J Pichler, F Heinz, C H Rieger.   

Abstract

The immunologic work-up of eight infants with the clinical diagnosis of severe combined immunodeficiency (SCID) was performed with special emphasis on natural killer (NK) cell function and ontogeny. Contrary to previous reports, our study shows that not all SCID patients lack NK activity; some may even express very high NK- and antibody-dependent cellular cytotoxicity (ADCC). The present group of eight SCID infants was homogeneous with respect to normal levels of the purine metabolism enzymes adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP). They all had low serum Ig levels and were defective for specific antibody formation against BSA and diphtheria toxin (DiT). None of the infants' peripheral blood mononuclear cells (PBMC) proliferated significantly upon in vitro stimulation with PHA, concanavalin A (Con A), pokeweed mitogen (PWM), and irradiated allogeneic lymphocytes. Seven of eight patients, however, responded significantly to mitogenic factors present in a lectin-free interleukin 2 (IL 2) preparation, and two exhibited a positive costimulation as well with simultaneous exposure to IL 2 + Con A. The lymphocyte marker analysis revealed high percentages of OKT10+ cells in seven of eight infants, whereas peripheral T cells (OKT3+) with suppressor/killer (OKT8+) or helper/inducer (OKT4+) phenotypes were abnormally low in all infants with one exception. The PBMC of two patients formed low to normal percentages of E rosettes but expressed no B cell markers (B-/SCID). The six other infants had high percentages of B cells (B+/SCID) but lacked E rosette-forming cells. High NK and ADCC activity was found in the two B-/SCID patients. The B+/SCID infants either totally lacked NK and ADCC function (four of six) or expressed low to normal NK activity together with some T cell markers as revealed by monoclonal antibody staining but not by E rosette formation (two of six). From the data presented, an ontogenic model is proposed that assumes the status of an independent cell lineage in between T cells and monocytes for human NK cells, or that places these cells in close proximity to early differentiation steps of the T cell lineage. In any case, NK cell function clearly constitutes an additional parameter of heterogeneity in the immunologic analysis of SCID.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415162

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  20-year anniversary of Children's Hospital of the Medical School Hannover and paediatric transplantation.

Authors:  J Brodehl
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

2.  The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder.

Authors:  W Müller; H H Peter; H C Kallfelz; A Franz; C H Rieger
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

3.  Natural killer (NK)-cell activity in sorted subsets of peripheral blood mononuclear cells from patients with severe combined immunodeficiency.

Authors:  R J ten Berge; P T Schellekens; A Budding-Koppenol; L J Dooren; J M Vossen
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

4.  Deficiency of NK activity of HNK-1+ cells after transplantation of fetal thymus and liver or haploidentical soybean agglutinin-treated marrow cells in two severe combined immunodeficiency patients.

Authors:  Y I Gotoh; Y Yamaguchi; M Minegishi; T Konno; K Tada
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

Review 5.  The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome.

Authors:  W Müller; H H Peter; M Wilken; H Jüppner; H C Kallfelz; H P Krohn; K Miller; C H Rieger
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

6.  Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors.

Authors:  W Friedrich; S F Goldmann; W Ebell; R Blütters-Sawatzki; G Gaedicke; A Raghavachar; H H Peter; B Belohradsky; W Kreth; B Kubanek
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

7.  Early diagnosis of severe combined immunodeficiency syndrome.

Authors:  R A Hague; S Rassam; G Morgan; A J Cant
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

8.  Appearance of multiple benign paraproteins during early engraftment of soy lectin T cell-depleted haploidentical bone marrow cells in severe combined immunodeficiency.

Authors:  P Ghory; S Schiff; R Buckley
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

9.  Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.

Authors:  R Bacchetta; B A Vandekerckhove; J L Touraine; M Bigler; S Martino; L Gebuhrer; J E de Vries; H Spits; M G Roncarolo
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Phenotypical and functional heterogeneity of the large granular lymphocytes increased after various treatments in a patient with combined immunodeficiency.

Authors:  S Takagi; J Minakuchi; H Okawa; J Yata
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.